Innovating Works

LEANBIO

Activa
Phoenix: Pharmaceutical Open Innovation Test Bed for Enabling Nano pharmaceutical Innovative Products LUXEMBOURG INSTITUTE OF SCIENCE AND TECHNOLOGY tramitó un H2020: H2020-NMBP-TO-IND-2018-2020 Nano-pharmaceuticals have the potential to drive the scientific and technological uplift, offering great clinical and socio-economic benefit...
2020-12-16 - 2025-02-28 | Financiado
Smart-4-Fabry: Smart multifunctional GLA nanoformulation for Fabry disease CENTRO DE INVESTIGACION BIOMEDICA EN RED CIBER tramitó un H2020: H2020-NMBP-2016-2017 Lysosomal storage disorders (LSD) diseases are a group of rare diseases that currently lack a definitive cure. LSD incidence is about 1:5,00...
2016-11-22 - 2020-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.